Health Care·Life Sciences Tools & Services·$32.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.81 | N/A | -2.64% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $0.81 | N/A | -2.64% |
| Revenue | N/A | N/A | N/A |
Tone: Defensive
Management expressed concerns about the current market conditions but emphasized their commitment to operational efficiency. They did not provide specific guidance for future quarters.
We are navigating a challenging environment with cautious optimism.
Our focus remains on maintaining operational efficiency.
Agilent Technologies reported an EPS of $0.81, slightly missing expectations, which contributed to a 1.2% decline in stock price. The lack of revenue data and forward guidance adds uncertainty for investors. Management's cautious tone suggests they are preparing for potential challenges ahead.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
VERISK ANALYTICS INC A
Feb 18, 2020